Old Web
English
Sign In
Acemap
>
authorDetail
>
M. Besche
M. Besche
Testosterone
Pathology
Hormone
Doxorubicin
Chemotherapy
2
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Initial results of ongoing phase I/II studies of weekly doxorubicin (Doxo)/docetaxel (Doce) in men with hormone refractory (HRPC) and hormone sensitive prostate cancer (HSPC)
2005
Journal of Clinical Oncology
Heather D. Mannuel
Nancy A. Dawson
I. Khan
M. Feldman
L. Boyle
M. Besche
Jeanne Smoot
C. Engstrom
M. Monroe
Arif Hussain
Show All
Source
Cite
Save
Citations (1)
Phase I/II trial of weekly doxorubicin (Doxo)/docetaxel (Doce) followed by hormone ablation (HA) in recurrent prostate cancer (PC)
2004
Journal of Clinical Oncology
Heather D. Mannuel
Nancy A. Dawson
Chuanfa Guo
Brenda Dorsey
M. Besche
Jeanne Smoot
C. Engstrom
Arif Hussain
Show All
Source
Cite
Save
Citations (0)
1
map